Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 19, 2026

Laparoscopic Anatomical Liver Segment VII Resection with Liver Parenchymal Transection Following a Priority Approach
13:57

Laparoscopic Anatomical Liver Segment VII Resection with Liver Parenchymal Transection Following a Priority Approach

Published on: May 23, 2025

Surgical Considerations for Primary Liver Neoplasms.

Dillon C Cheung1, Chee-Chee Stucky2

  • 1Department of Surgery, Mayo Clinic Arizona, Phoenix, AZ, USA.

Hematology/Oncology Clinics of North America
|June 17, 2026
PubMed
Summary

Primary liver cancers like hepatocellular carcinoma and intrahepatic cholangiocarcinoma have poor survival rates. Surgical resection offers the best prognosis, with advanced therapies aiding resectability in select cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ASO Visual Abstract: Do Postoperative Complications Impact Adjuvant Chemotherapy for Patients Undergoing Left-Side Pancreatectomy for Pancreatic Cancer?

Annals of surgical oncology·2026
Same author

ASO Author Reflections: It's Not "Just" a Distal Pancreatectomy: The Impact of Postoperative Complications on Adjuvant Therapy Delivery in Left-Side Pancreatic Cancer.

Annals of surgical oncology·2026
Same author

Do Postoperative Complications Impact Adjuvant Chemotherapy in Patients Undergoing Left-Side Pancreatectomy for Pancreatic Cancer?

Annals of surgical oncology·2026
Same author

De-Escalating Surgery for 1-2 cm Appendiceal Neuroendocrine Tumors: A North American Multi-Center Analysis.

Journal of surgical oncology·2026
Same author

The Association of Extended Venous Thromboembolism Prophylaxis and Venous Thromboembolism After Cancer Surgery.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Financial Toxicity Following Locally Advanced Rectal Cancer Treatment.

Diseases of the colon and rectum·2026

Area of Science:

  • Hepatobiliary surgery
  • Surgical oncology
  • Gastroenterology

Background:

  • Primary liver neoplasms, including hepatocellular carcinoma and intrahepatic cholangiocarcinoma, represent a significant global health challenge.
  • These cancers are associated with poor survival outcomes and limited effective systemic treatment options.
  • Accurate preoperative assessment is crucial for determining surgical candidacy.

Purpose of the Study:

  • To outline the essential components of preoperative assessment for liver neoplasms.
  • To discuss the role of surgical resection and minimally invasive techniques.
  • To explore strategies for managing advanced but potentially resectable liver tumors.

Main Methods:

  • Comprehensive preoperative evaluation including advanced imaging, liver function tests, and future liver remnant (FLR) volumetry.
Keywords:
Future liver remnantHepatic artery infusion chemotherapyHepatocellular carcinomaIntrahepatic cholangiocarcinomaLiver resectionMinimally invasive surgeryNeoadjuvant therapyPortal vein embolization

More Related Videos

Modified Laparoscopic Anatomic Hepatectomy: Two-Surgeon Technique Combined with the Simple Extracorporeal Pringle Maneuver
12:27

Modified Laparoscopic Anatomic Hepatectomy: Two-Surgeon Technique Combined with the Simple Extracorporeal Pringle Maneuver

Published on: June 16, 2023

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy
04:41

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Published on: March 10, 2023

Related Experiment Videos

Last Updated: Jun 19, 2026

Laparoscopic Anatomical Liver Segment VII Resection with Liver Parenchymal Transection Following a Priority Approach
13:57

Laparoscopic Anatomical Liver Segment VII Resection with Liver Parenchymal Transection Following a Priority Approach

Published on: May 23, 2025

Modified Laparoscopic Anatomic Hepatectomy: Two-Surgeon Technique Combined with the Simple Extracorporeal Pringle Maneuver
12:27

Modified Laparoscopic Anatomic Hepatectomy: Two-Surgeon Technique Combined with the Simple Extracorporeal Pringle Maneuver

Published on: June 16, 2023

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy
04:41

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Published on: March 10, 2023

  • Surgical resection aiming for negative margins.
  • Application of minimally invasive surgical approaches in selected patients.
  • Neoadjuvant therapies such as chemotherapy, portal vein embolization (PVE), radiation lobectomy, and hepatic artery infusion chemotherapy (HAIC) for downstaging.
  • Main Results:

    • Surgical resection with clear margins provides the best opportunity for long-term survival in primary liver neoplasms.
    • Minimally invasive surgical techniques are increasingly utilized for eligible patients, potentially reducing morbidity.
    • Neoadjuvant strategies can facilitate tumor downstaging, converting initially unresectable disease into a resectable state.

    Conclusions:

    • Effective management of primary liver neoplasms necessitates a multidisciplinary approach integrating accurate preoperative assessment and tailored treatment strategies.
    • Surgical resection remains the cornerstone of curative treatment, with advancements in surgical techniques and neoadjuvant therapies expanding resectability.
    • Further research into systemic therapies and innovative downstaging techniques is warranted to improve outcomes for patients with advanced liver cancer.